Compounds > tibolone
Page last updated: 2024-08-16

tibolone and Adenocarcinoma, Basal Cell

tibolone has been researched along with Adenocarcinoma, Basal Cell in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's5 (62.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, SB; Lee, SJ; Park, DC; Yeo, SG1
Arteaga-Gómez, AC; Castellanos-Barroso, G; Colin-Valenzuela, A; García-Vargas, J; Márquez-Acosta, G; Reyes-Muñoz, E1
Contreras, L; Rodriguez, T; Sahid, S; Yazigi, R1
Blok, LJ; Burger, CW; De Gooyer, ME; Gielen, SC; Hanifi-Moghaddam, P; Kloosterboer, HJ; Moorhouse, M; Sijbers, AM; Smid, M; van Gool, AJ; van Wijk, FH1
Khalil, AM; Nassar, AH; Seoud, MA; Usta, IM1
Bracke, ME; Depypere, HT; Kloosterboer, HJ; Vanhoecke, BW1
Archer, DF; Mirkin, S1
Gillmer, MD; Gray, MD; McEwan, HP; Pyper, RJ; Rollason, TP; von Dadelszen, P; Wright, A1

Other Studies

8 other study(ies) available for tibolone and Adenocarcinoma, Basal Cell

ArticleYear
Attitudes and practices of Korean gynecologists towards hormone replacement therapy in endometrial cancer survivors.
    European journal of gynaecological oncology, 2013, Volume: 34, Issue:6

    Topics: Adenocarcinoma; Adult; Attitude of Health Personnel; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Gynecology; Hormone Replacement Therapy; Humans; Hysterectomy; Male; Menopause, Premature; Middle Aged; Neoplasm Grading; Neoplasm Staging; Norpregnenes; Ovariectomy; Practice Patterns, Physicians'; Republic of Korea; Salpingectomy; Surveys and Questionnaires; Time Factors

2013
[Hormone therapy effect in postmenopausal women with history of endometrial cancer].
    Ginecologia y obstetricia de Mexico, 2011, Volume: 79, Issue:1

    Topics: Adenocarcinoma; Adult; Carcinoma, Adenosquamous; Carcinoma, Endometrioid; Comorbidity; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Neoplasm Staging; Norpregnenes; Postmenopause; Recurrence; Retrospective Studies; Smoking

2011
Carcinoma of the endometrium in patients treated with tibolone.
    Gynecologic oncology, 2004, Volume: 93, Issue:2

    Topics: Adenocarcinoma; Aged; Anabolic Agents; Androgen Antagonists; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Norpregnenes

2004
Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:2

    Topics: Adenocarcinoma; Cell Differentiation; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Nerve Net; Norpregnenes; Progestins; Transcription, Genetic

2005
Endometrial adenocarcinoma after prolonged tibolone therapy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 90, Issue:1

    Topics: Adenocarcinoma; Brachytherapy; Diagnosis, Differential; Drug Administration Schedule; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage

2005
Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
    Maturitas, 2006, Jun-20, Volume: 54, Issue:3

    Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor Modulators; Female; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Norpregnenes; Osteoporosis, Postmenopausal

2006
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
    Maturitas, 2007, Aug-20, Volume: 57, Issue:4

    Topics: Adenocarcinoma; Angiopoietin-1; Cell Line, Tumor; Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Receptor Modulators; Female; Humans; Medroxyprogesterone Acetate; Norpregnenes; Receptor, TIE-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Necrosis Factor-alpha

2007
Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:2

    Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Menopause; Middle Aged; Norpregnenes

1994